Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06464341 · ClinicalTrials.gov registry record
Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study
A clinical trial, sponsored by University Hospital, Basel, Switzerland.
- Completed
- Registry status
- 583
- Enrollment target
NCT06464341: Completed study, sponsored by University Hospital, Basel, Switzerland.
NCT06464341 is a clinical trial that has completed, run by University Hospital, Basel, Switzerland. The registered enrollment target is 583 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06464341 has completed, sponsored by University Hospital, Basel, Switzerland.
- COMPLETED
- Registry status
- 583 participants
- Enrollment target
Study Summary
The purposes of this multicenter retrospective cohort study are to determine the residual nodal burden in patients with isolated tumor cells detected in the SLN or the clipped node after NAC and to determine oncologic outcomes in this group of patients after ALND or nodal RT or observation.
Primary Outcome
Evaluation of the number of ALNDs performed
Interventions
- OTHER Observational study no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 583 participants |
| Start Date | 2023-05-04 |
| Est. Completion | 2024-12-31 |
What the finished NCT06464341 record still lists
NCT06464341 is an observational study that tracks outcomes without assigning an intervention. The registered 583 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Observational study no intervention is the first listed.
NCT06464341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06464341 about?
NCT06464341 is a clinical study titled "Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study". The purposes of this multicenter retrospective cohort study are to determine the residual nodal burden in patients with isolated tumor cells detected in the SLN or the clipped node after NAC and to determine oncologic outcomes in this group of patients after ALND or nodal RT or observation.
What is the current status of trial NCT06464341?
This trial is currently completed. The enrollment target is 583 participants. The study started on 2023-05-04. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT06464341?
The interventions under investigation include: Observational study no intervention (OTHER).
Who is sponsoring clinical trial NCT06464341?
This trial is sponsored by University Hospital, Basel, Switzerland, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03840083 · 584 participants · NA
Sleep-dependent Learning in Aging
- NCT04984291 · 584 participants · NA
Zimmer Biomet Shoulder Arthroplasty PMCF
- NCT05983757 · 584 participants · NA
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
- NCT06569290 · 584 participants · NA
Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI